Update
$Ocular Therapeutix(OCUL.US$ Ocular Therapeutix™ Announces FDA Agreement to Amend Special Protocol Assessment (SPA) for Pivotal Clinical Trial of AXPAXLI™ in Wet AMD 2 MINUTES AGO, 8:00 AM EST VIA GLOBENEWSWIRE![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
